查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球乳房再造市场
市场调查报告书
商品编码
1279673

2023-2030 年全球乳房再造市场

Global Breast Reconstruction Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球乳房再造市场预计将实现利润丰厚的增长，到 2022 年将达到 5.7433 亿美元，到 2030 年将达到 9.343 亿美元。 预计该市场在预测期内（2023-2030 年）的复合年增长率为 6.4%。

乳房重建术使用多种整形外科技术使乳房在乳房切除术后恢復到接近正常的状态。 植入物重建和皮瓣重建是乳房重建的两种主要类型。 在植入重建中，乳房植入物用于创建新的乳房小丘。 皮瓣（或自体）重建使用从身体另一部分取出的患者自身组织来创建新的乳房。

市场动态

乳房再造治疗意识的提高正在推动乳房再造市场的增长

意识的提高归功于独立机构和市场进入者的行动。 例如，2021 年 10 月 22 日，植入物製造商 AbbVie 将发起一场展示重建可能性的活动。 通过新的“你的力量”活动，这家乳房植入物製造商希望改变这种状况。 该活动颂扬患者的勇气和内在毅力，并教育他们了解乳房重建的选择。 虽然该活动没有品牌，但该公司的乳房再造产品包括组织扩张器、植入物输送套管和 Natrelle 品牌植入物。

此外，为了提高人们对乳房再造的认识，塔塔纪念中心举办了一场名为“再造与癌症护理”的会议。 由于上述因素，预计乳房再造市场将在整个预测期内处于领先地位。

随着 3D 打印机专用植入物的开发，预计将实现商业扩张

3D 打印植入物的开发可能为商业扩张带来可观的前景。 例如，2023 年 4 月 6 日，乳房植入物将由 CollPlant 和 Stratasys 进行生物打印。 该公司与 CollPlant 合作，具有利用生物打印技术转变医疗保健并改善接受隆胸和修復治疗患者生活的巨大潜力。

CollPlant 和 Stratasys 签订了联合开发和商业化协议，以推进生物打印技术的发展。 该合作伙伴关係将结合 Stratasys 基于 P3 技术的生物打印机与 CollPlant 基于 rhCollagen 的生物墨水。 可编程光聚合，称为 P3，是数字光处理 (DLP) 技术的发展，旨在大规模製造有用的最终用途组件。

COVID-19 影响分析

市场暂时受到 COVID-19 大流行的影响，其中大部分处于爆发的早期阶段。 限制和停工导致正在进行和预定的外科手术被推迟或取消，阻碍了乳房植入物市场的扩张。 然而，在美国女性中 COVID-19 流行期间，人们对外观的兴趣和意识有所提高，包括隆胸和植入物。 因此，市场有望从 COVID-19 大流行的影响中恢復和发展。

俄乌战争影响分析

由于俄乌战争在该地区的渗透率较低且缺乏主要市场参与者，因此估计对全球乳房再造市场的影响较小。 然而，在预测期内，原材料、试验产品和设备的进出口影响预计对全球乳房再造市场影响不大。

人工智能影响分析

得益于 Breast Advocate 应用程序，人工智能有望对全球乳房再造市场产生积极影响，Breast Advocate 应用程序是世界上第一个用于乳房再造和癌症手术的共享决策工具。 这个应用程序是一个免费的应用程序，它允许任何被诊断出患有乳腺癌或有患乳腺癌风险的人在他们的手术选择中有发言权。 这个应用程序是由乳腺癌医生和患者活动家共同创建的。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品类型
  • 按形状
  • 按展示位置
  • 最终用户
  • 按地区

第四章市场动态

  • 影响因素
    • 主持人
      • 全球乳腺癌发病率上升
      • 提高对乳房重建治疗的认识
    • 约束因素
      • 乳房手术的费用很高
    • 机会
      • 介绍 3D 打印植入物
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第七章俄乌战争分析

第8章人工智能的影响分析

第 9 章按产品类型

  • 植入
  • 组织扩张器
  • 无细胞真皮基质

第10章按形状

  • 圆形
  • 解剖形状

第 11 章按位置

  • 双平面插入
  • 腺下插入
  • 筋膜下插入部位

第 12 章最终用户

  • 医院
  • 门诊手术中心
  • 其他

第13章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 俄罗斯
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第14章竞争格局

  • 竞争场景
  • 市场份额分析
  • 併购分析

第十五章公司简介

  • 艾尔建公司
    • 公司简介
    • 按产品类型分类的产品组合和内容
    • 财务摘要
    • 主要发展状况
  • Sientra, Inc
  • IDEAL IMPLANT INCORPORATED
  • Johnson & Johnson
  • Establishment Labs S.A.
  • GC Aesthetics
  • Groupe Sebbin SAS
  • Ideal Implant Incorporated
  • Laboratoires Arion
  • Mentor Worldwide LLC.

第16章 附录

简介目录
Product Code: MD6133

Market Overview

The global breast reconstruction market reached US$ 574.33 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 934.30 million by 2030. The market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).

Breast reconstruction uses several plastic surgical techniques to return a breast to a state that is very close to normal after a mastectomy. Implant-based reconstruction and flap reconstruction are the two main types of breast reconstruction. Breast implants are used in implant reconstruction to create a new breast mound. Flap (or autologous) reconstruction creates a new breast using the patient's own tissue from another area of the body.

Market Dynamics

Growing Awareness About Breast Reconstruction Treatment is Driving the Breast Reconstruction Market Growth.

The increase in awareness can be attributed to actions made by independent bodies and market participants. For instance, on October 22, 2021, AbbVie, an implant manufacturer, develops a campaign to showcase reconstruction possibilities. With its new "Power of You" campaign, the breast implant manufacturer hopes to change that. The initiative honors patients' bravery and inner fortitude while educating them on their options for breast reconstruction. Although the campaign is unbranded, the company's breast reconstruction products include tissue expanders, implant delivery sleeves, and Natrelle-branded implants.

Additionally, to raise awareness of breast reconstruction, Tata Memorial Centre organized a conference titled Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer on February 17, 2022. As a result of the aforementioned factors, the breast reconstruction market is anticipated to lead throughout the forecast period.

The Development of 3D-printed Implants May Present Considerable Prospects for Commercial Expansion.

The development of 3D-printed implants may present considerable prospects for commercial expansion. For instance, on April 06, 2023, Breast implants will be bioprinted by CollPlant and Stratasys. The company has a significant chance to use bioprinting to alter healthcare and better the lives of patients undergoing breast augmentation or repair treatments thanks to its cooperation with CollPlant.

To advance the development of bioprinting technology, CollPlant, and Stratasys inked a combined development and commercialization agreement. The collaboration will pair Stratasys' P3 technology-based bioprinter with CollPlant's rhCollagen-based bio-inks. Programmable PhotoPolymerization, also known as P3, is a development of digital light processing (DLP) technology intended for the bulk manufacturing of useful end-use components.

COVID-19 Impact Analysis

The market was temporarily impacted by the COVID-19 pandemic, mostly during the pandemic's early stages. The ongoing and scheduled surgical procedures were postponed or canceled as a result of the limitations and lockout, which hampered the expansion of the breast implant market. However, during the COVID-19 pandemic among women in the United States, interest and growing awareness regarding physical appearance, including breast augmentation and implants, increased. As a result, the market is anticipated to rebound from the COVID-19 pandemic's effects and develop.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global breast reconstruction market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global Breast reconstruction market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global breast reconstruction market positively owing to the Breast Advocate app being the first shared decision-making tool for breast reconstruction and cancer surgery in the world. It is a free app that gives anybody with a breast cancer diagnosis or at risk of getting breast cancer a voice in the choices made about their surgery. It was co-created by breast cancer doctors and patient activists.

Segment Analysis

The global breast reconstruction market is segmented based on product type, shape, placement, end-user, and region.

The Round Shape Segment is Estimated to Hold a Majority of the Breast Reconstruction Market Share During the Forecast Period.

The round shape holds about 56% of the total breast reconstruction market in the forecast period owing to the acceptance of new products by different permitting bodies. The dominance can be due to the increase in product announcements, the FDA's regular updates on the safety of breast implants, and the execution of several clinical investigations.

For instance, GC Aesthetics will introduce the PERLE, a new generation of round silicone breast implants, in May 2021. In order to ensure that patients undergoing breast implant surgery have enough information, the U.S. FDA amended its safety guidelines for breast implants in October 2021 and prohibited the sales and distribution of breast implants. Therefore, round-shaped breast implants are anticipated to experience significant growth as a result of the aforementioned factors.

Geographical Analysis

Asia Pacific is Estimated to Hold the Second-largest Share of the Global Breast Reconstruction Market During the Forecast Period.

The Asia Pacific region holds the second largest share of the global breast reconstruction market accounting for approximately 33% in the forecast period. The rise in awareness of breast reconstruction surgery and the fast-rising breast cancer population are both responsible for the growth.

For instance, the NCBI data revealed that there were approximately 303,600 new instances of breast cancer and 70,400 fatalities from the disease in China. Furthermore, according to a similar source, the incidence rate and mortality rate in China are predicted to rise by 2030 due to changing demographics and risks. More than 76.5% of women preferred breast reconstruction following mastectomy, according to research by a similar source.

Competitive Landscape

The major global players in the market include: Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, and Mentor Worldwide LLC, among others.

Why Purchase the Report?

  • To visualize the global breast reconstruction market segmentation based on product type, shape, placement, end user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of breast reconstruction market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global Breast reconstruction market report would provide approximately 69 tables, 66 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Shape
  • 3.3. Snippet by Placement
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
      • 4.1.1.2. Growing Awareness about breast reconstruction treatment
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth
    • 4.1.3. Opportunity
      • 4.1.3.1. The introduction of 3D-printed implants may present significant advantages market expansion opportunities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.1.2. Market Attractiveness Index, By Product Type
  • 9.2. Implants
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Tissue Expander
  • 9.4. Acellular Dermal Matrix

10. By Shape

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 10.1.2. Market Attractiveness Index, By Shape
  • 10.2. Round Shape
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Anatomical Shape

11. By Placement

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 11.1.2. Market Attractiveness Index, By Placement
  • 11.2. Dual Plane Insertion
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Subglandular Insertion
  • 11.4. Submuscular Insertion

12. By End User

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.1.2. Market Attractiveness Index, By End User
  • 12.2. Hospitals
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Ambulatory Surgical Centers
  • 12.4. Others

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Russia
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Market Share Analysis
  • 14.3. Mergers and Acquisitions Analysis

15. Company Profiles

  • 15.1. Allergan Plc
    • 15.1.1. Company Overview
    • 15.1.2. Product Type Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. Sientra, Inc
  • 15.3. IDEAL IMPLANT INCORPORATED
  • 15.4. Johnson & Johnson
  • 15.5. Establishment Labs S.A.
  • 15.6. GC Aesthetics
  • 15.7. Groupe Sebbin SAS
  • 15.8. Ideal Implant Incorporated
  • 15.9. Laboratoires Arion
  • 15.10. Mentor Worldwide LLC.

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us